PL3452051T3 - Kompozycja zawierająca hmos do zastosowania w leczeniu nadwrażliwości trzewnej i/lub bólu trzewnego mediowanych komórkami tucznymi - Google Patents

Kompozycja zawierająca hmos do zastosowania w leczeniu nadwrażliwości trzewnej i/lub bólu trzewnego mediowanych komórkami tucznymi

Info

Publication number
PL3452051T3
PL3452051T3 PL17792541.9T PL17792541T PL3452051T3 PL 3452051 T3 PL3452051 T3 PL 3452051T3 PL 17792541 T PL17792541 T PL 17792541T PL 3452051 T3 PL3452051 T3 PL 3452051T3
Authority
PL
Poland
Prior art keywords
hmos
pain
treatment
composition
mast cell
Prior art date
Application number
PL17792541.9T
Other languages
English (en)
Inventor
Louise Kristine VIGSNÆS
Bruce Mcconnell
Emma ELISON
Original Assignee
Glycom A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US15/147,115 external-priority patent/US20160243139A1/en
Application filed by Glycom A/S filed Critical Glycom A/S
Publication of PL3452051T3 publication Critical patent/PL3452051T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
PL17792541.9T 2016-05-05 2017-05-05 Kompozycja zawierająca hmos do zastosowania w leczeniu nadwrażliwości trzewnej i/lub bólu trzewnego mediowanych komórkami tucznymi PL3452051T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15/147,115 US20160243139A1 (en) 2014-10-29 2016-05-05 Composition comprising HMSs/HMOs and use thereof
PCT/DK2017/050146 WO2017190755A1 (en) 2016-05-05 2017-05-05 Composition comprising hmos for use in the treatment of mast cell mediated visceral hypersensitivity and/or pain

Publications (1)

Publication Number Publication Date
PL3452051T3 true PL3452051T3 (pl) 2022-11-14

Family

ID=60202799

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17792541.9T PL3452051T3 (pl) 2016-05-05 2017-05-05 Kompozycja zawierająca hmos do zastosowania w leczeniu nadwrażliwości trzewnej i/lub bólu trzewnego mediowanych komórkami tucznymi

Country Status (5)

Country Link
EP (1) EP3452051B1 (pl)
DK (1) DK3452051T3 (pl)
ES (1) ES2924137T3 (pl)
PL (1) PL3452051T3 (pl)
WO (1) WO2017190755A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111683666A (zh) * 2017-12-22 2020-09-18 格礼卡姆股份公司 预防或减少伤害感受的包含hmo的组合物
US20220193099A1 (en) * 2019-04-09 2022-06-23 Intrinsic Medicine, Inc. Immunomodulatory oligosaccharides for the treatment of pain
EP4076474A4 (en) * 2019-12-06 2024-02-28 Glycom As COMPOSITION CONTAINING 2'-FL AND DFL FOR USE IN A PAIN RELIEF METHOD
CN116490082A (zh) * 2020-12-04 2023-07-25 雀巢产品有限公司 用于在个体中使用以支持睡眠模式成熟的包含人乳低聚糖的组合物

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2796082B1 (fr) 1999-07-07 2003-06-27 Centre Nat Rech Scient Procede de production d'oligosaccharides
US8507227B2 (en) 2006-03-09 2013-08-13 Centre National De La Recherche Scientifique (Cnrs) Method of producing sialylated oligosaccharides
WO2010008491A2 (en) * 2008-06-25 2010-01-21 Ritter Natural Sciences, Llc Lactose compositions with decreased lactose content
US8852785B2 (en) 2009-03-05 2014-10-07 Nissan Motor Co., Ltd. Bipolar secondary battery and method for producing the same
US8425930B2 (en) * 2009-03-13 2013-04-23 The Regents Of The University Of California Prebiotic oligosaccharides
MX2011010214A (es) 2009-04-07 2012-01-20 Glycom As Sintesis de 2'-o-fucosil-lactosa.
CN105330705A (zh) 2010-02-19 2016-02-17 格礼卡姆股份公司 用于制备含n-乙酰乳糖胺的四糖乳糖-n-新四糖(lnnt)的方法
WO2012009315A2 (en) * 2010-07-12 2012-01-19 The Regents Of The University Of California Bovine milk oligosaccharides
RU2013106896A (ru) 2010-07-16 2014-08-27 Глюком А/С Синтез новых производных сиалоолигосахаридов
EP2455387A1 (en) * 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
SG191393A1 (en) 2010-12-31 2013-08-30 Abbott Lab Neutral human milk oligosaccharides to promote growth of beneficial bacteria
US20140046044A1 (en) 2011-02-21 2014-02-13 Glycom A/S Novel glycosyl phosphites
RU2013146524A (ru) 2011-03-18 2015-04-27 Глюком А/С Синтез новых фукозо-содержащих производных углеводородов
US9234225B2 (en) 2011-05-13 2016-01-12 Glycom A/S Method for generating human milk oligosaccharides (HMOs) or precursors thereof
CN103703012A (zh) 2011-05-13 2014-04-02 格礼卡姆股份公司 乳糖-n-四糖的制造
JP6106160B2 (ja) 2011-05-13 2017-03-29 グリコム アー／エスＧｌｙｃｏｍ Ａ／Ｓ 人乳オリゴ糖（ｈｍｏ）又はその前駆体の多様化
WO2013044928A1 (en) 2011-09-30 2013-04-04 Glycom A/S Synthesis of hmo core structures
WO2013091660A1 (en) 2011-12-23 2013-06-27 Glycom A/S A method for obtaining crystalline lacto-n-tetraose and lacto-n-neotetraose precursors and mixtures thereof
WO2013139344A1 (en) 2012-03-20 2013-09-26 Glycom A/S Synthesis of the trisaccharide 3-o-fucosyllactose and intermediates thereof
US20160243139A1 (en) * 2014-10-29 2016-08-25 Glycom A/S Composition comprising HMSs/HMOs and use thereof
CN107073021A (zh) * 2014-10-29 2017-08-18 格礼卡姆股份公司 合成组合物以及用于治疗肠易激综合症的方法
EP3368046B1 (en) * 2015-10-28 2022-07-27 Glycom A/S Synthetic composition and method for modulating brain function and behaviour
WO2019121929A1 (en) * 2017-12-22 2019-06-27 Societe Des Produits Nestle S.A. Compositions for use in the reduction of nociception in infants and young children

Also Published As

Publication number Publication date
EP3452051A4 (en) 2020-01-08
EP3452051A1 (en) 2019-03-13
DK3452051T3 (en) 2022-09-05
ES2924137T3 (es) 2022-10-04
WO2017190755A1 (en) 2017-11-09
EP3452051B1 (en) 2022-06-01

Similar Documents

Publication Publication Date Title
EP3325473A4 (en) Compounds and uses thereof in the treatment of cancer and other medical disorders
GB201411496D0 (en) Use of 7-Oh-Cannabidiol (7-Oh-CBD) and/or 7-Oh-Cannabidvarin (7-Oh-CBDV) in the treatment of epilepsy
IL261932A (en) Use of probiotics in the treatment and/or prevention of eczema
ZA201704726B (en) Peptides and their use in the treatment of skin
IL282836A (en) 5-halouracil - modified micro RNAs and their use in cancer treatment
DK3681857T3 (en) Fluorophenyl beta-hydroxyethylamines and their use in the treatment of hyperglycaemia
DK3452051T3 (en) COMPOSITION COMPRISING HMOs FOR USE IN THE TREATMENT OF MAST CELL MEDIATED VISCERAL HYPERSENSITIVITY AND/OR PAIN
IL272414A (en) Use of gaboksadol in the treatment of diabetes and related conditions
GB201514021D0 (en) Novel Pyridines and their use in the treatment of cancer
IL263988A (en) Useful preparations in the prevention and / or treatment of arthritis, pain and damage to cartilage
IL270978B (en) Grape skin for use in the treatment of dysbiosis
ZA201801402B (en) SELECTED AMIDE OF γ -HYDROXYBUTYRIC ACID AND USES THEREOF IN THE TREATMENT OF ALCOHOL MISUSE
GB201710822D0 (en) Methods and medical uses relating to the treatment of hypoglycaemia
PL3373922T3 (pl) Kompozycje i sposoby do stosowania do leczenia homocystynurii
SG11201704486TA (en) Improvements in and relating to the treatment of matrices and/or the contents of matrices
EP3518951C0 (en) COMPOSITIONS FOR USE IN THE TREATMENT OF OSTEOPOROSIS AND Fractures
EP3380112A4 (en) PEPTIDES AND THEIR USE IN THE TREATMENT OF HAIR
GB201514015D0 (en) Novel pyridazinones and their use in the treatment of cancer
SG11201802955VA (en) Peptides of use in the preventive and curative treatment of alopecia
IL261240B (en) Preparations useful in the prevention and/or treatment of inflammation and pain
PT3268378T (pt) Galactolípido para utilização na cicatrização de feridas e para utilização na prevenção e/ou tratamento do envelhecimento cutâneo
IL243402A0 (en) Methods for identifying preparations for use in the treatment of heart diseases and the use of preparations for the treatment of these diseases
GB201421263D0 (en) Improvements in and relating to the treatment of matrices and/or the content ofmatrices